Browse studies

Find your next paid study

27,306 recruiting studies available now

Phase II Non-Randomized Trial of Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients

This is a research study to evaluate change in Quality of Life, as defined by the European Organization for Research and Treatment of Cancer Quality of Life Qu…

Liver CancerHepatocellular Carcinoma (HCC)

Estimated

~$10 – $750

Actual pay is set by the research site.

Duke UniversityNCT04933435

Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl

Background: A Timeline Follow-Back (TLFB) is a tool that helps researchers track how much of a substance a person uses. Different versions of the tool are use…

Substance Use Disorders (SUDs)

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute on Drug Abuse (NIDA)NCT06995885

Observational

Ora Secunda Cerclage Laser Retinopexy To Prevent Retinal Detachment In Stickler Syndrome (OSC/SS): A Prospective Historically Controlled Study

The goal of this clinical trial is to prospectively document to what extent the OSC/SS prophylactic laser retinopexy procedure works to prevent retinal detachm…

Stickler Syndrome Type 1Stickler Syndrome Type 2

Estimated

~$10 – $750

Actual pay is set by the research site.

Helen Keller Eye Research FoundationNCT07146516

Observational

A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients With Acute Kidney Injury Requiring Continuous Kidney Replacement Therapy

This randomized, controlled, pivotal study is intended to determine whether up to ten sequential 24-hour treatments with the Selective Cytopheretic Device (SCD…

Acute Kidney Injury

Estimated

~$10 – $1,125

Actual pay is set by the research site.

SeaStar MedicalNCT05758077

Phase 2

AN INTERVENTIONAL PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, THIRD PARTY-UNBLINDED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE EFFICACY AND SAFETY OF PF-07275315 IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. COPD is a co…

Moderate to Severe Chronic Obstructive Pulmonary Disease

Estimated

~$75 – $3,000

Actual pay is set by the research site.

PfizerNCT07363694

Observational

A Phase II Study Assessing the Efficacy of BRain-AVOidant Proton Craniospinal Irradiation (CSI) for Leptomeningeal Metastases (LM) From Solid Tumor Malignancies (BRAVO-LM)

The purpose of this study is to determine the efficacy of BRain-AVOidant proton craniospinal irradiation (BRAVO pCSI) in adult participants with leptomeningeal…

Leptomeningeal MetastasisBreast CancerLung Cancer (NSCLC)

Estimated

~$10 – $750

Actual pay is set by the research site.

University of MiamiNCT07789912

Phase 1

Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks

This study tests whether certain medicines and a skin treatment can slow down or partly reverse the body's aging process. As people age, the activity of their…

Aging

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Frontiers in Bioscience Research Institute and AgingNCT07888595

Phase 1

A Phase 1/2 Multicenter Study Evaluating the Safety and Efficacy of LYL273 in Patients With Relapsed or Refractory Metastatic Colorectal Cancer

This is a Phase 1/2 open-label, multicenter study evaluating the safety and efficacy of LYL273 in participants with relapsed or refractory metastatic colorecta…

Colorectal Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Lyell Immunopharma, Inc.NCT05319314

Phase 2

A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Induction and Maintenance Therapy With PALI-2108 in Participants With Moderately to Severely Active Ulcerative Colitis

The ASCENTRA-UC study is a phase 2 study testing PALI-2108 in patients with moderate to severe ulcerative colitis. Doses of drug will be compared against a pla…

Ulcerative Colitis (UC)Severe Ulcerative ColitisModerate Ulcerative Colitis

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Palisade BioNCT07845487

Phase 1

Phase 1/2, Open-Label Study of the Safety, Dosimetry and Efficacy of a 3-Dose Regimen of Escalating Doses of 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer

Background: Oncocytic (Hurthle cell) thyroid cancer (HTC) is a rare disease with few treatment options. Researchers are developing a radioactive drug that tar…

Thyroid Cancer

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT06991738

Validation of the Vestibular Migraine Patient Assessment Tool and Handicap Inventory (VM-PATHI) for Adolescents

Vestibular migraine (VM) is the most common cause of episodic dizziness in children and adults. Dizziness, especially in conjunction with other migraine sympto…

Vestibular Migraine

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston Children's HospitalNCT07532109

Phase 2

A Phase 2/3 Study to Characterize and Evaluate the Efficacy, Safety, and Tolerability of hu14.18K322A Treatment Given in Combination With Chemotherapy in Participants With High-Risk Neuroblastoma

Neuroblastoma is the most common type of solid cancer found outside the brain in young children. Generally, it affects children younger than 5 years old, with …

High-Risk Neuroblastoma

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Renaissance Pharma Ltd.NCT07549321